ectonucleotide pyrophosphatase/phosphodiesterase 1
Last updated 19 Mar 2026
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The ENPP1 gene provides instructions for making a protein that helps break down a molecule called adenosine triphosphate (ATP). Specifically, the ENPP1 protein breaks down ATP that is found outside of cells (extracellular). Extracellular ATP is quickly broken down into other molecules called adenosine monophosphate (AMP) and pyrophosphate. Pyrophosphate is important for preventing the accumulation of abnormal deposits of calcium (calcification) and other minerals (mineralization) in the body.
Video picks for GenesVideo library
Normal function
The ENPP1 gene provides instructions for making a protein that helps break down a molecule called adenosine triphosphate (ATP). Specifically, the ENPP1 protein breaks down ATP that is found outside of cells (extracellular). Extracellular ATP is quickly broken down into other molecules called adenosine monophosphate (AMP) and pyrophosphate. Pyrophosphate is important for preventing the accumulation of abnormal deposits of calcium (calcification) and other minerals (mineralization) in the body.
The ENPP1 protein also plays a role in the cell signaling that occurs in response to the hormone insulin. Part of the ENPP1 protein, called the SMB2 domain, interacts with the insulin receptor, which is a protein that binds to insulin and initiates cell signaling. Insulin plays many roles in the body. It helps regulate levels of blood glucose (also called blood sugar) by controlling how much glucose passes from the bloodstream into cells to be used as energy. Insulin is also important for the maintenance of the outer layer of skin (the epidermis). It helps control the transport of the pigment melanin from the cells that produce it (melanocytes) to epidermal cells called keratinocytes. Insulin is also involved in the development of keratinocytes.
Conditions referring to this gene or chromosome
Other names
PC-1
PCA1
Patient picks for Genes

PID Q&A
Does PID cause bleeding?
Dr Sarah Jarvis MBE Symptoms may develop quickly. You can become quite ill over a few days. Sometimes symptoms are mild and develop slowly. For example, you may just have a mild abdominal pain that may 'grumble on' for weeks. In some cases no symptoms develop and you do not know that you are infected. However, you are still at risk of complications even if you have no symptoms at first. [https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1](https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1)
by Dr Sarah Jarvis

PID Q&A
How do you diagnose PID?
Dr Sarah Jarvis MBE Symptoms may develop quickly. You can become quite ill over a few days. Sometimes symptoms are mild and develop slowly. For example, you may just have a mild abdominal pain that may 'grumble on' for weeks. In some cases no symptoms develop and you do not know that you are infected. However, you are still at risk of complications even if you have no symptoms at first. [https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1](https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1)
by Dr Sarah Jarvis

Other diabetes
What does insulin do?
Dr Partha Kar In type 1 diabetes, the body stops making insulin and the blood sugar level goes very high. Some people who have type 2 diabetes may also need to have insulin injections to help control blood sugar levels. Insulin is usually injected under the skin between 2-4 times a day. For more information on insulin, go to [https://patient.info/health/type-1-diabetes/insulins](https://patient.info/health/type-1-diabetes/insulins)
by Dr Partha Kar, FRCP

Type 1 diabetes
How do you know if you have type 1 diabetes?
Dr Partha Kar The symptoms tend to develop quite quickly, over a few days or weeks. After treatment is started, the symptoms soon settle and go. However, without treatment, the blood sugar (glucose) level becomes very high and acids form in the bloodstream (ketoacidosis). [https://patient.info/health/type-1-diabetes#nav-1](https://patient.info/health/type-1-diabetes#nav-1)
by Dr Partha Kar, FRCP

Type 1 diabetes
How does type 1 diabetes affect your weight?
Dr Partha Kar The symptoms that usually occur when you first develop type 1 diabetes are: thirst, regular passing of urine, tiredness, weight loss and feeling generally unwell. For more information on type 1 diabetes, go to [https://patient.info/health/type-1-diabetes](https://patient.info/health/type-1-diabetes)
by Dr Partha Kar, FRCP

Risks of diabetes
What can someone with type 1 diabetes do to stop their glucose going too high?
Dr Sarah Jarvis MBE For more information on continuous glucose monitoring, go to [https://patient.info/health/type-1-diabetes/features/continuous-glucose-monitoring-in-type-1-diabetes](https://patient.info/health/type-1-diabetes/features/continuous-glucose-monitoring-in-type-1-diabetes)
by Dr Sarah Jarvis
Related patient information and medicines

Patient information leaflet
Haemophilia
When. Haemophilia is a condition where there is a deficiency of clotting factors, so people with this condition usually have prolonged bleeding. There is no cure but with available treatments most people with haemophilia are able to live normal lives. What is haemophilia. Haemophilia is a rare bleeding disorder caused by deficiency of clotting.

Patient information leaflet
Giant Cell Arteritis
Prompt treatment aims to prevent serious complications such as severe sight impairment which can occur soon after the disease starts. What is giant cell arteritis. Giant cell arteritis (GCA), also known as temporal arteritis, is a condition which causes inflammation on the inside of some blood vessels (arteries). It is called 'giant cell' because.

Patient information leaflet
Wilson's disease
Wilson's disease is a genetic disorder in which copper builds up in the body, mainly in the liver and brain. Without any treatment, the build-up of copper can cause serious symptoms. Treatment is with medication to remove the excess copper and/or to prevent a further build-up of copper. What is Wilson's disease. Wilson's disease is a condition.

Patient information leaflet
Kidney biopsy
A kidney biopsy involves taking a small sample of tissue from the kidney. Cells from the kidney can then be looked at in detail. It is used to diagnose and monitor certain conditions. Note : the information below is a general guide only. The arrangements, and the way tests are performed, may vary between different hospitals. Always follow the.

Patient information leaflet
Down's syndrome screening
This causes the typical features of Down's syndrome. See the separate leaflet called Down's syndrome for more details Down's syndrome. What increases your chance of having a b... The chromosomes in their blood can then be examined to look for an extra chromosome 21. The rest of this leaflet concentrates on screening for Down's syndrome and the.

Patient information leaflet
Sickle cell trait
If you inherit a gene from one of your parents, called a sickle cell gene, you have a condition called sickle cell trait. If you inherit a sickle cell gene from both parents, you get a double dose of the sickle cell gene. This causes a condition called sickle cell disease (SCD). What is sickle cell trait. Sickle cell trait means having one gene.
Further reading and references
- ectonucleotide pyrophosphatase/phosphodiesterase 1; MedlinePlus, National Library of Medicine.
- Bacci S, De Cosmo S, Prudente S, Trischitta V. ENPP1 gene, insulin resistance and related clinical outcomes. Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):403-9. doi: 10.1097/MCO.0b013e3281e386c9.
- Collins L, Sandy J, Ly S, Lomax KE, Black S, McKenzie F, Hayes E, Poulton C, Jefferies C, Hunter W, Simm P, Rodda C, Biggin A, Munns C, Siafarikas A. Six cases of ENPP1 pathogenic variants causing autosomal recessive hypophosphatemic rickets type 2 and generalized arterial calcification of infancy. JBMR Plus. 2025 Dec 6;9(Suppl 5):v47-v57. doi: 10.1093/jbmrpl/ziae174. eCollection 2025 Dec.
- Edouard T, Linglart A. Autosomal recessive hypophosphatemic rickets type 2 due to ENPP1 deficiency (ARHR2). Arch Pediatr. 2024 Sep;31(4S1):4S27-4S32. doi: 10.1016/S0929-693X(24)00154-4.
- Eytan O, Morice-Picard F, Sarig O, Ezzedine K, Isakov O, Li Q, Ishida-Yamamoto A, Shomron N, Goldsmith T, Fuchs-Telem D, Adir N, Uitto J, Orlow SJ, Taieb A, Sprecher E. Cole Disease Results from Mutations in ENPP1. Am J Hum Genet. 2013 Oct 3;93(4):752-7. doi: 10.1016/j.ajhg.2013.08.007. Epub 2013 Sep 26.
- Galletti S, Nitschke Y, Malavolti AM, Aquilano G, Faldella G, Corvaglia L, Rutsch F. Generalized Arterial Calcification of Infancy: Fatal Clinical Course Associated with a Novel Mutation in ENPP1. JIMD Rep. 2011;1:23-7. doi: 10.1007/8904_2011_11. Epub 2011 Jun 25.
- Kalal IG, Seetha D, Panda A, Nitschke Y, Rutsch F. Molecular diagnosis of generalized arterial calcification of infancy (GACI). J Cardiovasc Dis Res. 2012 Apr;3(2):150-4. doi: 10.4103/0975-3583.95373.
- Lorenz-Depiereux B, Schnabel D, Tiosano D, Hausler G, Strom TM. Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet. 2010 Feb 12;86(2):267-72. doi: 10.1016/j.ajhg.2010.01.006. Epub 2010 Feb 4.
- Nitschke Y, Baujat G, Botschen U, Wittkampf T, du Moulin M, Stella J, Le Merrer M, Guest G, Lambot K, Tazarourte-Pinturier MF, Chassaing N, Roche O, Feenstra I, Loechner K, Deshpande C, Garber SJ, Chikarmane R, Steinmann B, Shahinyan T, Martorell L, Davies J, Smith WE, Kahler SG, McCulloch M, Wraige E, Loidi L, Hohne W, Martin L, Hadj-Rabia S, Terkeltaub R, Rutsch F. Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet. 2012 Jan 13;90(1):25-39. doi: 10.1016/j.ajhg.2011.11.020. Epub 2011 Dec 29.
- Ralph D, Levine MA, Richard G, Morrow MM, Flynn EK, Uitto J, Li Q. Mutation update: Variants of the ENPP1 gene in pathologic calcification, hypophosphatemic rickets, and cutaneous hypopigmentation with punctate keratoderma. Hum Mutat. 2022 Sep;43(9):1183-1200. doi: 10.1002/humu.24391. Epub 2022 May 18.
- Ruf N, Uhlenberg B, Terkeltaub R, Nurnberg P, Rutsch F. The mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy (GACI). Hum Mutat. 2005 Jan;25(1):98. doi: 10.1002/humu.9297.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

